UPB
Income statement / Annual
Last year (2024), Upstream Bio, Inc.'s total revenue was $2.37 M,
a decrease of 0.42% from the previous year.
In 2024, Upstream Bio, Inc.'s net income was -$62.81 M.
See Upstream Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$2.37 M |
$2.38 M |
$1.21 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$2.37 M
|
$2.38 M
|
$1.21 M
|
| Gross Profit Ratio |
1
|
1
|
1
|
| Research and Development Expenses |
$62.97 M
|
$31.80 M
|
$18.66 M
|
| General & Administrative Expenses |
$17.17 M
|
$10.70 M
|
$6.46 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$17.17 M
|
$10.70 M
|
$6.46 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$80.13 M
|
$42.49 M
|
$25.12 M
|
| Cost And Expenses |
$80.13 M
|
$42.49 M
|
$25.12 M
|
| Interest Income |
$12.12 M
|
$4.17 M
|
$205.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$89.00 K
|
$60.00 K
|
$7.00 K
|
| EBITDA |
-$77.68 M |
-$40.05 M |
-$23.90 M |
| EBITDA Ratio |
-32.77
|
-16.83
|
-19.72
|
| Operating Income Ratio |
-32.81
|
-16.85
|
-19.73
|
| Total Other Income/Expenses Net |
$14.96 M
|
$19.58 M
|
$41.00 K
|
| Income Before Tax |
-$62.81 M
|
-$20.54 M
|
-$23.87 M
|
| Income Before Tax Ratio |
-26.5
|
-8.63
|
-19.69
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$62.81 M
|
-$20.54 M
|
-$23.87 M
|
| Net Income Ratio |
-26.5
|
-8.63
|
-19.69
|
| EPS |
-1.49 |
-1.05 |
-0.66 |
| EPS Diluted |
-1.49 |
-1.05 |
-0.66 |
| Weighted Average Shares Out |
$51.34 M
|
$36.32 M
|
$36.32 M
|
| Weighted Average Shares Out Diluted |
$51.34 M
|
$36.32 M
|
$36.32 M
|
| Link |
|
|
|
